HROWNasdaqPharmaceutical PreparationsFiscal year ends December 31
HARROW, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$27.68+0.40 (+1.47%)
Close on Oct 19, 2026
- Market cap
- $1.03B
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Mar 18, 2013(first seen in filings) | 1-for-5 reverse | Earlier per-share figures multiplied by 5 |
| Feb 8, 2013 | 1-for-5 reverse | Earlier per-share figures multiplied by 5 |
| Feb 24, 2012 | 1-for-8 reverse | Earlier per-share figures multiplied by 8 |